253 related articles for article (PubMed ID: 35872984)
1. Congenital Hyperinsulinism: Current Laboratory-Based Approaches to the Genetic Diagnosis of a Heterogeneous Disease.
Hewat TI; Johnson MB; Flanagan SE
Front Endocrinol (Lausanne); 2022; 13():873254. PubMed ID: 35872984
[TBL] [Abstract][Full Text] [Related]
2. Birth weight and diazoxide unresponsiveness strongly predict the likelihood of congenital hyperinsulinism due to a mutation in ABCC8 or KCNJ11.
Hewat TI; Yau D; Jerome JCS; Laver TW; Houghton JAL; Shields BM; Flanagan SE; Patel KA
Eur J Endocrinol; 2021 Oct; 185(6):813-818. PubMed ID: 34633981
[TBL] [Abstract][Full Text] [Related]
3. Monoallelic ABCC8 mutations are a common cause of diazoxide-unresponsive diffuse form of congenital hyperinsulinism.
Saint-Martin C; Zhou Q; Martin GM; Vaury C; Leroy G; Arnoux JB; de Lonlay P; Shyng SL; Bellanné-Chantelot C
Clin Genet; 2015 May; 87(5):448-54. PubMed ID: 24814349
[TBL] [Abstract][Full Text] [Related]
4. Investigating Genetic Mutations in a Large Cohort of Iranian Patients with Congenital Hyperinsulinism.
Razzaghy-Azar M; Saeedi S; Dayani SB; Enayati S; Abbasi F; Hashemian S; Eshraghi P; Karimdadi S; Tajdini P; Vakili R; Amoli MM; Yaghootkar H
J Clin Res Pediatr Endocrinol; 2022 Mar; 14(1):87-95. PubMed ID: 34927408
[TBL] [Abstract][Full Text] [Related]
5. ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide-unresponsive congenital hyperinsulinism.
Bellanné-Chantelot C; Saint-Martin C; Ribeiro MJ; Vaury C; Verkarre V; Arnoux JB; Valayannopoulos V; Gobrecht S; Sempoux C; Rahier J; Fournet JC; Jaubert F; Aigrain Y; Nihoul-Fékété C; de Lonlay P
J Med Genet; 2010 Nov; 47(11):752-9. PubMed ID: 20685672
[TBL] [Abstract][Full Text] [Related]
6. Genotype-phenotype correlation in Taiwanese children with diazoxide-unresponsive congenital hyperinsulinism.
Lee CT; Tsai WH; Chang CC; Chen PC; Fann CS; Chang HK; Liu SY; Wu MZ; Chiu PC; Hsu WM; Yang WS; Lai LP; Tsai WY; Yang SB; Chen PL
Front Endocrinol (Lausanne); 2023; 14():1283907. PubMed ID: 38033998
[TBL] [Abstract][Full Text] [Related]
7. Genotype and phenotype correlations in 417 children with congenital hyperinsulinism.
Snider KE; Becker S; Boyajian L; Shyng SL; MacMullen C; Hughes N; Ganapathy K; Bhatti T; Stanley CA; Ganguly A
J Clin Endocrinol Metab; 2013 Feb; 98(2):E355-63. PubMed ID: 23275527
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations.
Pinney SE; MacMullen C; Becker S; Lin YW; Hanna C; Thornton P; Ganguly A; Shyng SL; Stanley CA
J Clin Invest; 2008 Aug; 118(8):2877-86. PubMed ID: 18596924
[TBL] [Abstract][Full Text] [Related]
9. Novel dominant K
Boodhansingh KE; Kandasamy B; Mitteer L; Givler S; De Leon DD; Shyng SL; Ganguly A; Stanley CA
Am J Med Genet A; 2019 Nov; 179(11):2214-2227. PubMed ID: 31464105
[TBL] [Abstract][Full Text] [Related]
10. Clinical and genetic characteristics of patients with congenital hyperinsulinism in 21 non-consanguineous families from Serbia.
Raicevic M; Milenkovic T; Hussain K; Djordjevic M; Martic J; Todorovic S; Mitrovic K; Sarajlija A; Vukovic R
Eur J Pediatr; 2021 Sep; 180(9):2815-2821. PubMed ID: 33770274
[TBL] [Abstract][Full Text] [Related]
11. Focal congenital hyperinsulinism managed by medical treatment: a diagnostic algorithm based on molecular genetic screening.
Maiorana A; Barbetti F; Boiani A; Rufini V; Pizzoferro M; Francalanci P; Faletra F; Nichols CG; Grimaldi C; de Ville de Goyet J; Rahier J; Henquin JC; Dionisi-Vici C
Clin Endocrinol (Oxf); 2014 Nov; 81(5):679-88. PubMed ID: 24383515
[TBL] [Abstract][Full Text] [Related]
12. KATP channel mutations in congenital hyperinsulinism.
Saint-Martin C; Arnoux JB; de Lonlay P; Bellanné-Chantelot C
Semin Pediatr Surg; 2011 Feb; 20(1):18-22. PubMed ID: 21185999
[TBL] [Abstract][Full Text] [Related]
13. Clinical and genetic characterization of congenital hyperinsulinism in Spain.
Martínez R; Fernández-Ramos C; Vela A; Velayos T; Aguayo A; Urrutia I; Rica I; Castaño L;
Eur J Endocrinol; 2016 Jun; 174(6):717-26. PubMed ID: 27188453
[TBL] [Abstract][Full Text] [Related]
14. Insights in congenital hyperinsulinism.
Hussain K
Endocr Dev; 2007; 11():106-121. PubMed ID: 17986831
[TBL] [Abstract][Full Text] [Related]
15. Congenital Hyperinsulinism Caused by Novel Homozygous KATP Channel Gene Variants May Be Linked to Unexplained Neonatal Deaths among Kurdish Consanguineous Families.
Amaratunga SA; Hussein Tayeb T; Rozenkova K; Kucerova P; Pruhova S; Lebl J
Horm Res Paediatr; 2020; 93(1):58-65. PubMed ID: 32203961
[TBL] [Abstract][Full Text] [Related]
16. Therapies and outcomes of congenital hyperinsulinism-induced hypoglycaemia.
Banerjee I; Salomon-Estebanez M; Shah P; Nicholson J; Cosgrove KE; Dunne MJ
Diabet Med; 2019 Jan; 36(1):9-21. PubMed ID: 30246418
[TBL] [Abstract][Full Text] [Related]
17. Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism.
Kapoor RR; Flanagan SE; Arya VB; Shield JP; Ellard S; Hussain K
Eur J Endocrinol; 2013 Apr; 168(4):557-64. PubMed ID: 23345197
[TBL] [Abstract][Full Text] [Related]
18. Clinical Management and Gene Mutation Analysis of Children with Congenital Hyperinsulinism in South China.
Xu A; Cheng J; Sheng H; Wen Z; Lin Y; Zhou Z; Zeng C; Shao Y; Li C; Liu L; Li X
J Clin Res Pediatr Endocrinol; 2019 Nov; 11(4):400-409. PubMed ID: 31208162
[TBL] [Abstract][Full Text] [Related]
19. Perspective on the Genetics and Diagnosis of Congenital Hyperinsulinism Disorders.
Stanley CA
J Clin Endocrinol Metab; 2016 Mar; 101(3):815-26. PubMed ID: 26908106
[TBL] [Abstract][Full Text] [Related]
20. Partial ABCC8 gene deletion mutations causing diazoxide-unresponsive hyperinsulinaemic hypoglycaemia.
Flanagan S; Damhuis A; Banerjee I; Rokicki D; Jefferies C; Kapoor R; Hussain K; Ellard S
Pediatr Diabetes; 2012 May; 13(3):285-9. PubMed ID: 21978130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
